Intelligent Medicine Acquisition Corp. Warrant
IQMDW
IQMDW was delisted on the 26th of April, 2023.
0 hedge funds and large institutions have $0 invested in Intelligent Medicine Acquisition Corp. Warrant in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 48 closing their positions.
100% less funds holding
Funds holding: 49 → 0 (-49)
100% less capital invested
Capital invested by funds: $1.54M → $0 (-$1.54M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 48
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
-$1.03M |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$162K |
| 3 |
SCM
Saba Capital Management
New York
|
-$47.8K |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$32.9K |
| 5 |
Calamos Advisors
Naperville,
Illinois
|
-$28.8K |
IQMDW Hedge Fund Activity: Q2 2023 in Review
0 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Warrant (IQMDW) for Q2 2023, worth a combined $0 — down 100% from $1.54M a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of IQMDW and 0 opened new positions — a net loss of 48 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was LMR Partners, exiting entirely with an estimated $1.03M sold.
- 0 institutional investors held Intelligent Medicine Acquisition Corp. Warrant (IQMDW) as of Q2 2023, down from 49 in Q1 2023.
- Funds reported $0 of Intelligent Medicine Acquisition Corp. Warrant stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new Intelligent Medicine Acquisition Corp. Warrant positions in Q2 2023 and 48 closed out, a net change of -48 holders.
- The largest Intelligent Medicine Acquisition Corp. Warrant seller in Q2 2023 was LMR Partners, an estimated $1.03M sold.
Based on aggregated 13F filings for Q2 2023.